type I interferon IFN-alpha/beta response
Selected indexed studies
- IRF-7 is the master regulator of type-I interferon-dependent immune responses. (Nature, 2005) [PMID:15800576]
- Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19. (J Med Microbiol, 2023) [PMID:37526406]
- Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. (Nature, 2015) [PMID:25307056]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- IRF-7 is the master regulator of type-I interferon-dependent immune responses. (2005) pubmed
- Serum levels of type I interferon (IFN-I) is associated with the severity of COVID-19. (2023) pubmed
- Human intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation. (2015) pubmed
- Yeast β-glucan promotes antiviral type I interferon response via dectin-1. (2024) pubmed
- Type I interferon response in the central nervous system. (2007) pubmed
- Type I interferons (alpha/beta) in immunity and autoimmunity. (2005) pubmed
- The regulation of type I interferon production by paramyxoviruses. (2009) pubmed
- Trem2 regulates microglial migratory responses via type I interferon signaling during photoreceptor degeneration. (2025) pubmed
- Rubella Virus Triggers Type I Interferon Antiviral Response in Cultured Human Neural Cells: Involvement in the Control of Viral Gene Expression and Infectious Progeny Production. (2022) pubmed
- IFN-α/β/IFN-γ/IL-15 pathways identify GBP1-expressing tumors with an immune-responsive phenotype. (2024) pubmed